-
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-07-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test
-
The software offers both detailed, localized views of genomic data, and a whole genome view, in a format somewhat similar to the way Google presents items on the web. It is free to download and use. There are also some sample data files available. I like the idea of the heat map view...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-06-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, DNA, Genomics, Research, Pharmacogenomics, MIT, Biomed, Broad Institute, Harvard
-
The program uses just plain old Java, but add this technology with sequencing information and with the 4D applications, studies can be virtually conducted to see how a medication would react with selected settings. Its resolution is scaleable to 100,000,000 pixels and more by using more than one...
-
This is good, a genomics test that can give some preliminary results on whether or not statins will have an adverse effect before prescribing them. As the post states here, this is something that could certainly use some marketing to physicians. Zocor at 40 mg is a very common dosage and...
-
One CEO comes out and states how biotech will be the new focus for Glaxo, as in a related story whereby patients will require genetic testing for their AIDS drug, Ziagen. In the future I’m sure there will be more about big pharma and their biotech strategies as personalized medicine continues...
-
Warfarin is the second-most-likely drug, to cause adverse events requiring hospitalization. The use of warfarin sensitivity testing in the U.S. could avoid 85,000 serious-bleeding incidents. More in the way of personalized medicine and if you were a patient determined to have an adverse reaction...
-
Not too many years ago I remembered hearing the term “hospitalist” and asked what’s that? The hospitalist has evolved and is now one of the top growing professions. With Pharmacogenomics, we might be on the verge of a new specialty, a “Longevity Doctor”. We already have a dwindling...
-
The National Institute of Health sees the value of genetic profiles and is funding additional research. Duke University was the first client to use Expression Analysis and collaborates with the FDA and pharma for electronic submissions of data in an effort to accelerate drugs and diagnostics though...
-
Last month several Genomics companies received warning letters from the State of California and were told they needed to be licensed. 23andMe, which is an offshoot of Google may have a potential solution on the dilemma of the licensing issue with working with LabCorp, one of the largest labs...
-
Pfizer is wasting no time to get the calculations running and numbers rolling. To stay in the market, they are attempting to find out as much as they can about potential side effects and other perhaps adverse affects of their drugs. Better than they find up them front, as it will make for better...
-
We all recently heard about the warning letters sent from the state of California to firms selling online personal DNA sequencing over the Internet, and requiring a physician’s prescription for the service. One company DeCode, has taken the letter to heart and is revising their marketing plant...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
07-12-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, DNA, Genomics, Sequence, Pharmacogenomics, Diagnostics, CPT, DeCode
-
What can happen with clinical trials, the death of one participant, which has not been fully determined as to whether or not the drug was the cause, puts a halt to the study. Something to keep in mind when considering volunteering for a study, there are no guarantees here. This also makes...
-
This is one long, but very good video that explains Personalized Medicine from the ground up. If you want the basic understanding on how this is and will be working, listen up. Take time when you have the time to watch. This was done by UC-TV, University of California Television and...
-
This will enable to locate patients at risk of developing sporadic colorectal cancer and perhaps find pre-cancerous polyps ahead of time. This could also affect the time when an individual begins initial testing instead of the normal standards. More genomics research in the works. BD ...
-
Coriell University will begin offering free tests for 10,000 participants, and included is the education process to help both patients and physicians know what to do with the information. The Coriell project will offer a narrower range of results, and it will make a direct effort to involve...